01
Dietary Supplements

Ingredient-level tracking across five high-growth segments. Evidence quality, velocity, and regulatory risk mapped monthly.

Segments tracked

Vitamins & minerals  ·  Gut health  ·  Nootropics  ·  Beauty & longevity  ·  Women's health

View Supplement Intelligence →
02
OTC & Consumer Health

Over-the-counter category tracking across four therapeutic segments. Claim landscape, reformulation signals, Rx-to-OTC pipeline, and competitive brand moves.

Segments tracked

Pain management  ·  Respiratory health  ·  Gastrointestinal  ·  Dermatological

View OTC Intelligence →
03
Oral Health

Ingredient and technology tracking across five oral health segments. Clinical evidence, regulatory positioning, and branded ingredient moves mapped monthly.

Segments tracked

Caries prevention  ·  Periodontal care  ·  Aesthetic / cosmetic  ·  Denture care  ·  Specialised

View Oral Health Intelligence →

Latest signals  ·  Edition 05  ·  November 2026

Dietary Supplements
FTC escalates to a contempt motion against Amare Global over repeat health claims
Court dismisses Xlear's challenge to the FTC substantiation standard; the existing framework stands
Moringa Salmonella outbreak spans at least four supplement brands: 119 illnesses across 36 states
OTC & Consumer Health
Bemotrizinol reaches US shelves: first launch August 31, 2026, and the exclusivity clock is running
Oral phenylephrine final order still unpublished; effervescent bitartrate gets a narrow monograph path
Rextovy becomes the third naloxone Rx-to-OTC switch
Oral Health
A five-arm RCT gives early peri-implantitis a nonsurgical evidence base
CDT D2991 makes chairside hydroxyapatite regeneration billable; consumer claims remain blocked
New BLIS probiotic research is thin on caries and gum outcomes

How the intelligence is produced

01
Primary source monitoring

FDA and FTC databases, ClinicalTrials.gov, PubMed, and regulatory dockets tracked monthly. Retail velocity from SPINS and trade press. No aggregator dependency.

02
Consultant framing

Every signal is translated into a concrete implication. Not what happened — what a brand, investor, or advisory client should do with it. Three decades of category experience in every observation.

03
Transparent data quality

Intelligence is directional secondary-source analysis unless otherwise noted. Where SPINS or primary data underpins a finding, it is cited. I distinguish signal from noise — and say so when I cannot tell the difference.

Three verticals. Monthly cadence. Built for the practitioner who needs to know what's moving — and why it matters.

Explore the Intelligence →

Questions on any of this? Get in touch.